Schedule 13G ownership disclosure
NOVOGEN LTD
Security class unavailable
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000728889-15-000252
- Form type
- SC 13G
- Filer
- KAZIA THERAPEUTICS LTD
- CIK
- CIK 1075880
- Filed
- Feb 09, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership